15 Best U.S. Stocks to Buy Now Under $10
The U.S. has always been a financial and economic hub, home to some of the biggest companies in various sectors.
Sutro Biopharma Inc. (STRO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 7,708,690 | $22,586,462 | +34% | 0.82% |
| 2. | Point72 Asset Management Steve Cohen | 4,447,634 | $13,031,567 | +1607% | 0.03% |
| 3. | Millennium Management Israel Englander | 4,361,893 | $12,780,346 | -8% | 0% |
| 4. | BioImpact Capital Mpm Capital | 3,043,346 | $8,917,004 | -26% | 1.38% |
| 5. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 2,196,814 | $6,436,665 | +32% | 1.34% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.75 | 10,000 | Officer, Director | 116,525 | 2022-03-14 | Filing | |
| $7.75 | 64,516 | Officer, Director | 166,627 | 2020-05-14 | Filing | |
| $7.75 | 6,451 | Officer | 12,083 | 2020-05-14 | Filing | |
| $7.75 | 3,225 | Officer | 9,007 | 2020-05-14 | Filing | |
| $15.00 | 666,666 | Large Shareholder | 2,723,509 | 2018-10-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 12,185 | 12,803 | 2024-01-29 | Filing | ||
| $4.71 | 15,428 | Officer | 0 | 2023-08-28 | Filing | |
| $4.59 | 11,613 | Officer | 12,928 | 2023-08-25 | Filing | |
| $18.62 | 3,906 | Officer | 7,270 | 2021-09-28 | Filing | |
| $26.10 | 165 | Officer | 56,117 | 2021-01-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,823,922 | $24,984,625 | 0% | |
| 2. | 2,890,000 | $12,398,101 | 0% | |
| 3. | 2,762,636 | $11,851,709 | 0% | |
| 4. | 1,866,850 | $8,008,787 | 0% | |
| 5. | 1,259,237 | $5,402,674 | 0% |
News See All
Ken Fisher's 12 New Stock Picks
Before we begin to see what Ken Fisher is up to in the context of latest market movements, let’s see a hugely important paragraph from Fisher’s hedge fund’s Q2’2023 report.
11 Best Biotech Penny Stocks to Buy Now
As investors begin to see light at the end of the tunnel, their risk appetite, which had vanished amid recession risks and volatility, is coming back, creating chances of major investments in high-risk...
Top 5 Stock Picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we discuss the top 5 stock picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Is Sutro Biopharma, Inc. (STRO) Going to Burn These Hedge Funds?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Should I Avoid Sutro Biopharma, Inc. (STRO)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
10 Best Biotech Stocks to Buy According to Alan Frazier's Frazier Healthcare Partners
In this article, we discuss the 10 best biotech stocks to buy according to Alan Frazier.
Is Sutro Biopharma, Inc. (STRO) A Good Stock To Buy?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is STRO Stock A Buy or Sell?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Billionaire Hedge Funds
